# Novo Nordisk A/S - Inspection Records

Source: https://www.globalkeysolutions.net/companies/novo-nordisk-as/b48359f1-0bb7-4fff-80dd-688aab40951b

> Inspection records and compliance data for Novo Nordisk A/S in Kalundborg, None. Access full analysis and detailed observations.

---

## Details

- Name: Novo Nordisk A/S
- FEI Number: 3002807751
- City: Kalundborg
- State: None
- Country Name: Denmark
- Address Line 1: Hallas Alle 1
- Zip Code: None

## Related Documents

- [483 - Novo Nordisk A/S - 2024-03-25](https://www.globalkeysolutions.net/records/483/novo-nordisk-as/a1d0c5be-baef-49e2-8029-c33585c3f80a) — source: FDA, date: March 25, 2024
- [MEMO - Novo Nordisk A/S - 2024-03-25](https://www.globalkeysolutions.net/records/memo/novo-nordisk-as/c64eef41-5e75-4ec1-8077-7d00df21947b) — source: FDA, date: March 25, 2024
- [EIR - Novo Nordisk A/S - 2024-03-25](https://www.globalkeysolutions.net/records/eir/novo-nordisk-as/e5940682-7d77-485a-a366-11b1f33ca5dc) — source: FDA, date: March 25, 2024
- [483 - Novo Nordisk A/S - 2024-03-25](https://www.globalkeysolutions.net/records/483/novo-nordisk-as/da5518cf-dd42-4d5b-b2f7-bdbb6dd3182c) — source: FDA, date: March 25, 2024
- [483 - Novo Nordisk A/S - 2023-05-04](https://www.globalkeysolutions.net/records/483/novo-nordisk-as/c88acfb5-d361-4369-8bff-87d2b9102820) — source: FDA, date: May 4, 2023
- [FDA Inspection 1209127 - Novo Nordisk A/S - 2023-05-04](https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-as/66074870-de76-43e2-b8fd-c93d30311f61) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 4, 2023
- [FDA Inspection 1230597 - Novo Nordisk A/S - 2022-12-02](https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-as/ec2db1ba-783d-4c1c-a74c-346bc1c8e086) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 2, 2022
- [FDA Inspection 1107225 - Novo Nordisk A/S - 2019-09-06](https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-as/5e409cfe-1857-4ba8-baa3-a761cd93fe2c) — classification: No Action Indicated (NAI), source: FDA, date: September 6, 2019
- [FDA Inspection 1028554 - Novo Nordisk A/S - 2017-08-29](https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-as/12a52ebf-09d5-4082-80b2-654c4163c444) — classification: No Action Indicated (NAI), source: FDA, date: August 29, 2017
- [FDA Inspection 872670 - Novo Nordisk A/S - 2014-03-07](https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-as/90013165-1edb-415a-86e7-07044abee0a0) — classification: No Action Indicated (NAI), source: FDA, date: March 7, 2014
- [FDA Inspection 861829 - Novo Nordisk A/S - 2013-05-10](https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-as/df1f0641-9b1d-40fb-8cd2-437a934efd7a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 10, 2013
- [FDA Inspection 777396 - Novo Nordisk A/S - 2012-03-09](https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-as/e1cb76c9-ac0c-4e4a-9edf-493cbc30c763) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 9, 2012
- [FDA Inspection 730949 - Novo Nordisk A/S - 2011-02-08](https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-as/c2bdc34c-1bf0-4727-8bcf-ef301839536a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 8, 2011
- [FDA Inspection 574834 - Novo Nordisk A/S - 2009-02-24](https://www.globalkeysolutions.net/records/fda_inspections/novo-nordisk-as/2d1e59aa-56e1-4106-9cc7-a9b9814866eb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 24, 2009

## Related Companies

- [Medinatura New Mexico, inc.](https://www.globalkeysolutions.net/companies/medinatura-new-mexico-inc/9ac6fb13-d04a-47c0-984a-ed542030da80)
- [Alto ICP, LLC](https://www.globalkeysolutions.net/companies/alto-icp-llc/bc6bac2f-8575-40c1-a90c-25f152eb71fd)
- [Chemspec Chemicals Private Limited](https://www.globalkeysolutions.net/companies/chemspec-chemicals-private-limited/1146fa48-6575-4871-9f9f-d0123a964d22)
- [Zhejiang Huahai Pharmaceutical](https://www.globalkeysolutions.net/companies/zhejiang-huahai-pharmaceutical/7742a83d-0a0c-4aed-9039-0b8b928ce70f)
- [Zhejiang Huahai Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/zhejiang-huahai-pharmaceutical-co-ltd/77f8f66f-ca2e-4b91-b460-a4bd2041c866)
- [Les Importations Herbasante Inc.](https://www.globalkeysolutions.net/companies/les-importations-herbasante-inc/3d1eca38-4416-426d-a7ef-529d1e50ddf2)
- [Curium US PET LLC](https://www.globalkeysolutions.net/companies/curium-us-pet-llc/0bdd3dc2-1a8a-46ec-819b-0a1d58ac2e15)
- [Honour Lab Limited](https://www.globalkeysolutions.net/companies/honour-lab-limited/527808a4-97a5-4c5b-8698-4dc2ab4bdeba)
- [King Bio Inc.](https://www.globalkeysolutions.net/companies/king-bio-inc/bad7278d-85cb-43ee-99a5-4cb9b13a45ea)
- [Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.](https://www.globalkeysolutions.net/companies/zhejiang-jinhua-conba-bio-pharm-co-ltd/ccf6fb2b-5de1-4f70-903b-d442374003f6)

## Related Officers

- [Program Expert for Advanced Manufacturing ](https://www.globalkeysolutions.net/people/prabhu-p-raju/2c0aaede-fe16-4431-bc21-614d7f18cb32)
- [Sergey S. Akimov](https://www.globalkeysolutions.net/people/sergey-s-akimov/4eca8d78-ef17-49a7-aaa1-5fa8fecf0383)
- [company_representative](https://www.globalkeysolutions.net/people/stefan-nielsen/26d381e5-bcc0-436b-8ddd-8abfbf61ed5d)
- [recipient](https://www.globalkeysolutions.net/people/mai-britt-hammer-frost-thomasen/32d1d2a1-b2e0-4804-9493-0ae74df4751d)
- [Ralph M. Bernstein](https://www.globalkeysolutions.net/people/ralph-m-bernstein/72173dfb-24ae-42a1-af9e-1dc7da02ed87)
- [Zachary Kraus](https://www.globalkeysolutions.net/people/zachary-kraus/9a85297e-4a21-49a6-a848-bc4a1e759f1a)
